- Home
- SKIL vs MNOV Comparison
SKIL vs MNOV Comparison
Compare SKIL & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKIL | MNOV |
|---|---|---|
| Founded | 1998 | 2000 |
| Country | United States | United States |
| Employees | 2261 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 72.7M |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | SKIL | MNOV |
|---|---|---|
| Price | $3.71 | $1.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | ★ 148.0K | 57.2K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $3.72 | $1.13 |
| 52 Week High | $23.00 | $1.96 |
Technical Indicators
Market Signals| Indicator | SKIL | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 31.34 | 40.30 |
| Support Level | $3.72 | $1.24 |
| Resistance Level | $4.84 | $1.36 |
| Average True Range (ATR) | 0.47 | 0.09 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 0.45 | 19.35 |
Price Performance
Historical ComparisonAbout SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.